Cargando…

The Benefits of Early Antiretroviral Therapy for HIV Infection: How Early is Early Enough?

Detalles Bibliográficos
Autores principales:	Lee, Sulggi A., Deeks, Steven G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5049928/ https://www.ncbi.nlm.nih.gov/pubmed/27515690 http://dx.doi.org/10.1016/j.ebiom.2016.08.009

Ejemplares similares

How early is enough in lactate monitoring?
por: Del Gaudio, S, et al.
Publicado: (2006)

Early antiretroviral treatment of infants to attain HIV remission: Not just a matter of timing
por: Faye, Albert
Publicado: (2020)

Pathogenesis of rheumatoid arthritis: how early is early?
por: Firestein, Gary S
Publicado: (2005)

Anti-HIV Antibody Responses and the HIV Reservoir Size during Antiretroviral Therapy
por: Lee, Sulggi A., et al.
Publicado: (2016)

Association of Endothelial Dysfunction and Antiretroviral Therapy in Early HIV Infection
por: Bush, Kelvin N. V., et al.
Publicado: (2019)

Oxygen “therapy” for infection in liver transplant surgery: less is more, enough is enough
por: Ho, Cheng-Maw, et al.
Publicado: (2023)

Early Antiretroviral Therapy reduces the incidence of otorrhea in a randomized study of early and deferred antiretroviral therapy: Evidence from the Children with HIV Early Antiretroviral Therapy (CHER) Study
por: Hainline, Clotilde, et al.
Publicado: (2011)

Further benefits by early start of HIV treatment in low income countries: Survival estimates of early versus deferred antiretroviral therapy
por: Johansson, Kjell Arne, et al.
Publicado: (2010)

Famines in Africa: is early warning early enough?
por: Kim, Jeeyon Janet, et al.
Publicado: (2012)

Maximizing the benefits of antiretroviral therapy for key affected populations
por: Grubb, Ian R, et al.
Publicado: (2014)

Quality of care: how good is good enough?
por: Chassin, Mark R
Publicado: (2012)

Thymic Output and CD4 T-Cell Reconstitution in HIV-Infected Children on Early and Interrupted Antiretroviral Treatment: Evidence from the Children with HIV Early Antiretroviral Therapy Trial
por: Lewis, Joanna, et al.
Publicado: (2017)

Temporal limits of therapeutic hypothermia onset in clinical trials for acute ischemic stroke: How early is early enough?
por: Lee, Hangil, et al.
Publicado: (2020)

Efavirenz-metabolizing polymorphisms, viral suppression, and depression in HIV-infected individuals initiating antiretroviral therapy in southwestern Uganda
por: Chang, Jonathan, et al.
Publicado: (2017)

Safer Conception Strategies for HIV-Serodiscordant Couples: How Safe Is Safe Enough?
por: Ciaranello, Andrea L., et al.
Publicado: (2015)

Antibiotics in childhood pneumonia: how long is long enough?
por: Grimwood, Keith, et al.
Publicado: (2016)

Persistent HIV-1 replication during antiretroviral therapy
por: Martinez-Picado, Javier, et al.
Publicado: (2016)

When to start antiretroviral therapy: the need for an evidence base during early HIV infection
por: Lundgren, Jens D, et al.
Publicado: (2013)

A Randomized Trial of Time-Limited Antiretroviral Therapy in Acute/Early HIV Infection
por: Margolick, Joseph B., et al.
Publicado: (2015)

HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study
por: Henrich, Timothy J., et al.
Publicado: (2017)

Early severe HIV disease precedes early antiretroviral therapy in infants: Are we too late?
por: Innes, Steve, et al.
Publicado: (2014)

Early career researchers benefit from inclusive, diverse and international collaborations: Changing how academic institutions utilize the seminar series
por: Febria, Catherine M., et al.
Publicado: (2022)

Impact of Early Initiation of Antiretroviral Therapy in Patients with Acute HIV Infection in Vienna, Austria
por: Herout, Sandra, et al.
Publicado: (2016)

Cost-Effectiveness of Early Versus Standard Antiretroviral Therapy in HIV-Infected Adults in Haiti
por: Koenig, Serena P., et al.
Publicado: (2011)

Effects of Antiretroviral Therapy on Autonomic Function in Early HIV Infection: A Preliminary Report
por: Chow, Dominic, et al.
Publicado: (2012)

When enough is enough: how the decision was made to stop the FEAST trial: data and safety monitoring in an African trial of Fluid Expansion As Supportive Therapy (FEAST) for critically ill children
por: Todd, Jim, et al.
Publicado: (2013)

Benefit of Early versus Deferred Antiretroviral Therapy on Progression of Liver Fibrosis among People with HIV in the START Randomized Trial
por: Dharan, Nila J., et al.
Publicado: (2019)

Central obesity & dyslipidemia in HIV patients on antiretroviral therapy
por: Kumar, Sanjay, et al.
Publicado: (2018)

How Useful Are Early Economic Models?: Comment on "Problems and Promises of Health Technologies: The Role of Early Health Economic Modelling"
por: Love-Koh, James
Publicado: (2019)

Harnessing circulating microRNAs for early HIV diagnosis
por: Vasan, Sandhya, et al.
Publicado: (2019)

LB2305. Long Term Benefits from Early Antiretroviral Therapy Initiation in HIV Infection: Findings from the Extended Follow-up of the START Trial
por: Babiker, Abdel G, et al.
Publicado: (2022)

HIV prevention is not enough: child survival in the context of prevention of mother to child HIV transmission
por: Kuhn, Louise, et al.
Publicado: (2009)

Impact of early antiretroviral therapy, early life immunity and immune sex differences on HIV disease and posttreatment control in children
por: Herbert, Nicholas G., et al.
Publicado: (2023)

Temporal trends of early mortality and its risk factors in HIV-infected adults initiating antiretroviral therapy in Uganda
por: Ssempijja, Victor, et al.
Publicado: (2020)

Combination anti‐HIV antibodies to achieve antiretroviral therapy‐free virological suppression in infected individuals
por: Rai, M. Ali, et al.
Publicado: (2022)

“Early goal-directed therapy” versus “Early” and “goal-directed” therapy for severe sepsis and septic shock: Time to rationalize
por: Dhooria, Sahajal, et al.
Publicado: (2015)

Perturbed CD8(+) T cell TIGIT/CD226/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals
por: Tauriainen, Johanna, et al.
Publicado: (2017)

Cardioneuroablation for treating functional bradyarrhythmias. How much is enough?
por: Pachon-M, J.C., et al.
Publicado: (2021)

Challenges in initiating antiretroviral therapy for all HIV-infected people regardless of CD4 cell count
por: Bigna, Jean Joel R., et al.
Publicado: (2016)

Identification of Immune Activation Profiles That May Predict Morbidity During Antiretroviral Therapy Treated HIV Infection
por: Funderburg, Nicholas T.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5os2drvvsq0nfveia8o8ia9hd4